-
公开(公告)号:US08940902B2
公开(公告)日:2015-01-27
申请号:US13554698
申请日:2012-07-20
申请人: R. Scott Bitner , Kaitlin E. Browman , Michael E. Brune , Yixian Chen , Jurgen Dinges , Karla Drescher , Peer Jacobson , Hwan-soo Jae , Ravi Kurukulasuriya , James T. Link , David J. Madar , Jyoti R. Patel , Marina A. Pliushchev , Jeffrey J. Rohde , Lynne E. Rueter , Qi Shuai , Bryan K. Sorensen , Jiahong Wang , Karsten M. Wicke , Martin Winn , Dariusz Wodka , Vince Yeh , Hong Yong
发明人: R. Scott Bitner , Kaitlin E. Browman , Michael E. Brune , Yixian Chen , Jurgen Dinges , Karla Drescher , Peer Jacobson , Hwan-soo Jae , Ravi Kurukulasuriya , James T. Link , David J. Madar , Jyoti R. Patel , Marina A. Pliushchev , Jeffrey J. Rohde , Lynne E. Rueter , Qi Shuai , Bryan K. Sorensen , Jiahong Wang , Karsten M. Wicke , Martin Winn , Dariusz Wodka , Vince Yeh , Hong Yong
IPC分类号: C07D211/74 , A61K31/44 , A61K31/495
CPC分类号: C07D403/12 , A61K31/44 , A61K31/495 , C07D207/267 , C07D401/12 , C07D401/14
摘要: A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-β-hydroxysteroid dehydrogenase Type 1 enzyme activity.
摘要翻译: 一种治疗患有与老化和神经变性相关的糖尿病中枢神经系统紊乱和缺陷的患者的方法,包括注意力缺陷障碍,注意力缺陷多动障碍(ADHD),阿尔茨海默病(AD),轻度认知障碍 老年性痴呆,艾滋病痴呆,神经退行性疾病,抑郁症和精神分裂症,包括向需要这种治疗的患者施用有效量的11-羟基类固醇脱氢酶1型酶活性的选择性抑制剂。
-
公开(公告)号:US07365093B2
公开(公告)日:2008-04-29
申请号:US11063476
申请日:2005-02-23
申请人: Martin Winn , Steven A. Boyd , Charles W. Hutchins , Hwan-Soo Jae , Andrew S. Tasker , Thomas W. von Geldern , Jeffrey A. Kester , Bryan K. Sorensen , Bruce G. Szczepankiewicz , Kenneth J. Henry , Gang Liu , Steven J. Wittenberger , Steven A. King
发明人: Martin Winn , Steven A. Boyd , Charles W. Hutchins , Hwan-Soo Jae , Andrew S. Tasker , Thomas W. von Geldern , Jeffrey A. Kester , Bryan K. Sorensen , Bruce G. Szczepankiewicz , Kenneth J. Henry , Gang Liu , Steven J. Wittenberger , Steven A. King
IPC分类号: A01N43/36 , C07D405/00
CPC分类号: C07D207/16 , C07D405/04 , C07D405/14 , C07D413/14
摘要: A compound of the formula (I): or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.
摘要翻译: 公开了式(I)化合物或其药学上可接受的盐,以及其制备方法和中间体,以及拮抗内皮素的方法。
-
公开(公告)号:US07208517B1
公开(公告)日:2007-04-24
申请号:US09653563
申请日:2000-08-31
申请人: Martin Winn , Steven A. Boyd , Charles W. Hutchins , Hwan-Soo Jae , Andrew S. Tasker , Thomas W. von Geldern , Jeffrey A. Kester , Bryan K. Sorensen , Bruce G. Szczepankiewicz , Kenneth J. Henry , Gang Liu , Steven J. Wittenberger , Steven A. King , Todd J. Janus , Robert J. Padley
发明人: Martin Winn , Steven A. Boyd , Charles W. Hutchins , Hwan-Soo Jae , Andrew S. Tasker , Thomas W. von Geldern , Jeffrey A. Kester , Bryan K. Sorensen , Bruce G. Szczepankiewicz , Kenneth J. Henry , Gang Liu , Steven J. Wittenberger , Steven A. King , Todd J. Janus , Robert J. Padley
IPC分类号: A61K31/40
CPC分类号: A61K31/40
摘要: A compound of the formula (I): or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, a method of antagonizing endothelin, methods for the inhibition of bone metastases, methods for the prevention of growth of new metastases, methods for the inhibition of bone turnover, and methods for the prevention of bone loss in patients, including cancer patients, using an endothelin ET-A receptor antagonist.
摘要翻译: 公开了式(I)化合物或其药学上可接受的盐,以及其制备方法和中间体,拮抗内皮素的方法,抑制骨转移的方法,预防生长的方法 的新转移,抑制骨转换的方法,以及使用内皮素ET-A受体拮抗剂预防患者(包括癌症患者)的骨丢失的方法。
-
公开(公告)号:US06946481B1
公开(公告)日:2005-09-20
申请号:US10266270
申请日:2002-10-08
申请人: Martin Winn , Steven A. Boyd , Charles W. Hutchins , Hwan-Soo Jae , Andrew S. Tasker , Thomas W. von Geldern , Jeffrey A. Kester , Bryan K. Sorensen , Bruce G. Szczepankiewicz , Kenneth J. Henry , Gang Liu , Steven J. Wittenberger , Steven A. King
发明人: Martin Winn , Steven A. Boyd , Charles W. Hutchins , Hwan-Soo Jae , Andrew S. Tasker , Thomas W. von Geldern , Jeffrey A. Kester , Bryan K. Sorensen , Bruce G. Szczepankiewicz , Kenneth J. Henry , Gang Liu , Steven J. Wittenberger , Steven A. King
IPC分类号: A61K31/40 , C07D207/00 , C07D405/04
CPC分类号: C07D405/04
摘要: A compound of the formula (I): or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.
摘要翻译: 公开了式(I)化合物或其药学上可接受的盐,以及其制备方法和中间体,以及拮抗内皮素的方法。
-
公开(公告)号:US6162927A
公开(公告)日:2000-12-19
申请号:US905913
申请日:1997-08-04
申请人: Martin Winn , Steven A. Boyd , Charles W. Hutchins , Hwan-Soo Jae , Andrew S. Tasker , Thomas W. von Geldern , Jeffrey A. Kester , Bryan K. Sorensen , Bruce G. Szczepankiewicz , Kenneth J. Henry , Gang Liu , Steven J. Wittenberger , Steven A. King
发明人: Martin Winn , Steven A. Boyd , Charles W. Hutchins , Hwan-Soo Jae , Andrew S. Tasker , Thomas W. von Geldern , Jeffrey A. Kester , Bryan K. Sorensen , Bruce G. Szczepankiewicz , Kenneth J. Henry , Gang Liu , Steven J. Wittenberger , Steven A. King
IPC分类号: C07D207/16 , C07D207/26 , C07D207/27 , C07D401/04 , C07D403/04 , C07D405/04 , C07D405/14 , C07D413/14 , C07D417/14 , C07F9/572 , C07F9/59 , C07D405/02 , C07D405/06 , A61K41/30 , A61N9/06 , A61N9/10
CPC分类号: C07D207/27 , C07D207/16 , C07D401/04 , C07D403/04 , C07D405/04 , C07D405/14 , C07D413/14 , C07D417/14 , C07F9/572 , C07F9/59
摘要: A compound of the formula (I): ##STR1## or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.
摘要翻译: 公开了式(I)化合物或其药学上可接受的盐,以及其制备方法和中间体,以及拮抗内皮素的方法。
-
公开(公告)号:US5120718A
公开(公告)日:1992-06-09
申请号:US714820
申请日:1991-06-13
申请人: Robert C. Goldman , William R. Baker , Hwan-Soo Jae , Biswanath De , Thomas M. Zydowsky , Edwin de Lara
发明人: Robert C. Goldman , William R. Baker , Hwan-Soo Jae , Biswanath De , Thomas M. Zydowsky , Edwin de Lara
IPC分类号: C07D207/26 , C07D207/273 , C07D295/215 , C07D295/26 , C07D401/06 , C07D417/06
CPC分类号: C07D207/273 , C07D295/215 , C07D295/26 , C07D401/06 , C07D417/06
摘要: Compounds which inhibit Candida acid protease are disclosed which have the formula: ##STR1## wherein R.sub.1 is loweralkyl, loweralkenyl, cycloalkyl, cycloalkenyl, cycloalkylalkyl, cycloalkenylalkyl, arylalkyl or (heterocyclic)alkyl;R.sub.2 is loweralkyl, cycloalkylalkyl or arylalkyl;R.sub.3 is --OH or --NH.sub.2 ;R.sub.4 is(a) --CH(OH)--R.sub.5 wherein R.sub.5 is loweralkyl, cycloalkyl or cycloalkylalkyl or(b) --CH.sub.2 CH(R.sub.6)C(O)NHR.sub.7 wherein R.sub.6 is loweralkyl and R.sub.7 is loweralkyl, aminoalkyl, alkylaminoalkyl, dialkylaminoalkyl, hydroxyalkyl, alkoxyalkyl, thioalkoxyalkyl, carboxyalkyl, alkoxycarbonylalkyl, cyanoalkyl or (heterocyclic)alkyl; andA is ##STR2## wherein R.sub.8 is arylalkyl, B is --C(O) or --S(O).sub.2 -- and R.sub.9 is aryl, arylalkyl, heterocyclic or (heterocyclic)alkyl; or ##STR3## wherein R.sub.10 is arylalkyl and R.sub.11 is (a) --C(O)R.sub.12 wherein R.sub.12 is alkoxy, arylalkoxy, aryl, arylalkyl, heterocyclic or (heterocyclic)alkyl or (b) --S(O).sub.2 --R.sub.13 wherein R.sub.13 is aryl, arylalkyl, heterocyclic or (heterocyclic)alkyl; or a pharmaceutically acceptable salt, ester or prodrug thereof.
摘要翻译: 公开了抑制假丝酵母酸蛋白酶的化合物,其具有下式:其中R 1是低级烷基,低级烯基,环烷基,环烯基,环烷基烷基,环烯基烷基,芳基烷基或(杂环)烷基; R2是低级烷基,环烷基烷基或芳基烷基; R3是-OH或-NH2; R4是(a)-CH(OH)-R5,其中R5是低级烷基,环烷基或环烷基烷基或(b)-CH2CH(R6)C(O)NHR7,其中R6是低级烷基,R7是低级烷基,氨基烷基,烷基氨基烷基,二烷基氨基烷基, ,烷氧基烷基,硫代烷氧基烷基,羧基烷基,烷氧基羰基烷基,氰基烷基或(杂环)烷基; (A)其中R8是芳基烷基,B是-C(O)或-S(O)2-,R9是芳基,芳烷基,杂环或(杂环)烷基; (b)其中R 10是芳烷基,R 11是(a)-C(O)R 12,其中R 12是烷氧基,芳基烷氧基,芳基,芳烷基,杂环或(杂环)烷基或(b)-S(O)2 -R13其中R13是芳基,芳烷基,杂环或(杂环)烷基; 或其药学上可接受的盐,酯或前药。
-
公开(公告)号:US20130059829A1
公开(公告)日:2013-03-07
申请号:US13554698
申请日:2012-07-20
申请人: R. Scott Bitner , Kaitlin E. Browman , Michael E. Brune , Yixian Chen , Jurgen Dinges , Karla Drescher , Peer Jacobson , Hwan-soo Jae , Ravi Kurukulasuriya , James T. Link , David J. Madar , Jyoti R. Patel , Marina A. Pliushchev , Jeffrey J. Rohde , Lynne E. Rueter , Qi Shuai , Bryan K. Sorensen , Jiahong Wang , Karsten M. Wicke , Martin Winn , Dariusz Wodka , Vince Yeh , Hong Yong
发明人: R. Scott Bitner , Kaitlin E. Browman , Michael E. Brune , Yixian Chen , Jurgen Dinges , Karla Drescher , Peer Jacobson , Hwan-soo Jae , Ravi Kurukulasuriya , James T. Link , David J. Madar , Jyoti R. Patel , Marina A. Pliushchev , Jeffrey J. Rohde , Lynne E. Rueter , Qi Shuai , Bryan K. Sorensen , Jiahong Wang , Karsten M. Wicke , Martin Winn , Dariusz Wodka , Vince Yeh , Hong Yong
IPC分类号: A61K31/5375 , A61K31/55 , A61K31/551 , A61K31/397 , A61K31/16 , A61P25/28 , A61P25/24 , A61P25/18 , A61P25/22 , A61K31/496 , A61P25/00
CPC分类号: C07D403/12 , A61K31/44 , A61K31/495 , C07D207/267 , C07D401/12 , C07D401/14
摘要: A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-β-hydroxysteroid dehydrogenase Type 1 enzyme activity.
-
公开(公告)号:US06228868B1
公开(公告)日:2001-05-08
申请号:US09360463
申请日:1999-07-23
申请人: Stephen L. Gwaltney, II , Hwan-Soo Jae , Douglas M. Kalvin , Gang Liu , Hing L. Sham , Qun Li , Akiyo K. Claiborne , Le Wang , Kenneth J. Barr , Keith W. Woods
发明人: Stephen L. Gwaltney, II , Hwan-Soo Jae , Douglas M. Kalvin , Gang Liu , Hing L. Sham , Qun Li , Akiyo K. Claiborne , Le Wang , Kenneth J. Barr , Keith W. Woods
IPC分类号: A61K31421
CPC分类号: C07D413/04 , C07D263/14
摘要: Compounds having Formula I are useful for treating cancer. Also disclosed are pharmaceutical compositions comprising compounds of Formula I, and methods of treating cancer in a mammal.
摘要翻译: 具有式Iare的化合物可用于治疗癌症。 还公开了包含式I化合物的药物组合物和治疗哺乳动物癌症的方法。
-
公开(公告)号:US5767144A
公开(公告)日:1998-06-16
申请号:US442575
申请日:1995-05-30
申请人: Martin Winn , Steven A. Boyd , Charles W. Hutchins , Hwan-Soo Jae , Andrew S. Tasker , Thomas W. von Geldern , Jeffrey A. Kester , Bryan K. Sorensen
发明人: Martin Winn , Steven A. Boyd , Charles W. Hutchins , Hwan-Soo Jae , Andrew S. Tasker , Thomas W. von Geldern , Jeffrey A. Kester , Bryan K. Sorensen
IPC分类号: C07D207/16 , C07D401/04 , C07D403/04 , C07D405/04 , C07D405/14 , C07F9/572 , C07F9/59 , A61K31/40 , C07D207/08
CPC分类号: C07D401/04 , C07D207/16 , C07D403/04 , C07D405/04 , C07D405/14 , C07F9/5722 , C07F9/592
摘要: A compound of the formula (I): ##STR1## or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.
摘要翻译: 公开了式(I)的化合物:其中(I)或其药学上可接受的盐,以及其制备方法和中间体,以及拮抗内皮素的方法。
-
公开(公告)号:US20100152179A9
公开(公告)日:2010-06-17
申请号:US12195937
申请日:2008-08-21
申请人: R. Scott Bitner , Kaitlin E. Browman , Michael E. Brune , Yixian Chen , Jurgen Dinges , Karla Drescher , Peer Jacobson , Hwan-soo Jae , Ravi Kurukulasuriya , James T. Link , David J. Madar , Jyoti R. Patel , Marina A. Pliushchev , Jeffrey J. Rohde , Lynne E. Rueter , Qi Shuai , Bryan K. Sorensen , Jiahong Wang , Karsten M. Wicke , Martin Winn , Dariusz Wodka , Vince Yeh , Hong Yong
发明人: R. Scott Bitner , Kaitlin E. Browman , Michael E. Brune , Yixian Chen , Jurgen Dinges , Karla Drescher , Peer Jacobson , Hwan-soo Jae , Ravi Kurukulasuriya , James T. Link , David J. Madar , Jyoti R. Patel , Marina A. Pliushchev , Jeffrey J. Rohde , Lynne E. Rueter , Qi Shuai , Bryan K. Sorensen , Jiahong Wang , Karsten M. Wicke , Martin Winn , Dariusz Wodka , Vince Yeh , Hong Yong
IPC分类号: A61K31/496 , A61P25/00 , A61K31/5375 , A61K31/445 , A61K31/16
CPC分类号: C07D403/12 , A61K31/44 , A61K31/495 , C07D207/267 , C07D401/12 , C07D401/14
摘要: A method for treating a patient suffering from disorders and deficits of the central nervous system associated with diabetes, associated with aging and neurodegeneration, comprising attention deficit disorder in general, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease (AD), mild cognitive impairment, senile dementia, AIDS dementia, neurodegeneration, depression, and schizophrenia, comprising administering to a patient in need of such treatment an effective amount of a selective inhibitor of the 11-β-hydroxysteroid dehydrogenase Type 1 enzyme activity.
摘要翻译: 一种治疗患有与老化和神经变性相关的糖尿病中枢神经系统紊乱和缺陷的患者的方法,包括注意力缺陷障碍,注意力缺陷多动障碍(ADHD),阿尔茨海默病(AD),轻度认知障碍 老年性痴呆,艾滋病痴呆,神经退行性疾病,抑郁症和精神分裂症,包括向需要这种治疗的患者施用有效量的11-羟基类固醇脱氢酶1型酶活性的选择性抑制剂。
-
-
-
-
-
-
-
-
-